US EditionFidelis Ayebae retires as Fidson CEO after 30 years
Summary by Billionaires.Africa
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Fidelis Ayebae retires as Fidson CEO after 30 years
Key PointsFidelis Ayebae steps down as CEO after growing Fidson into a $66 million pharmaceutical company since founding it in 1995.The company seeks $20 million via rights issue to fund expansion, as shareholders approve share capital increase to $1 million.Fidson’s net profit surged nearly 4x to $3.97 million in the first half, driven by strong ethical drug sales and revenue growth.Nigerian pharma mogul Fidelis Ayebae has stepped down as manag…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
